Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Express Scripts Reports Specialty Drug Spending Steadily Rising, And Pipelines Show More To Come

Apr 01 2011

• By Bridget Silverman

Related Content

Will Plavix Testing Be Enough To Limit Use Of Newer Antiplatelet Drugs?

Apr 18 2011

Companion Diagnostics: A Business Area Fraught With Challenges Ahead

Mar 15 2011

As Yervoy Launch Nears, Pricing Of Maintenance Therapy Remains A Key Question

Apr 11 2011

The Return Of Big Pharma? 2011 Novel Approvals Could Show Payoff Of Licensing And Acquisition Strategies

Feb 01 2011

Targeted Oncologics ISO Companion Diagnostics To Find Attractive Patients

Feb 01 2011

For NMEs, The Song Remains The Same: Specialty Markets Eye Further Growth For 2010, While Traditional Big Pharma, Primary Care NDAs Are Few

Feb 01 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window